Skip to main content
SpringerLink
Log in

Dual fronts poised to transform melanoma therapy

  • News Feature
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

With recent successes of immunotherapies and targeted drugs, melanoma has become one of the most dynamic areas of anticancer drug development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullard, A. Dual fronts poised to transform melanoma therapy. Nat Rev Drug Discov 10, 325–326 (2011). https://doi.org/10.1038/nrd3441

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3441

  • Springer Nature Limited

Search

Navigation